ProKidney Corp.
PROK | NASDAQ
$1.77
-$0.14 (-7.33%)
At close: Sep 21, 2026, 4:00 PM ET
$1.77
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 893K | 76K | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 893K | 76K | n/a | n/a | n/a | n/a |
Operating Income | -165.01M | -183.68M | -151.52M | -153.01M | -55.11M | -27.02M |
Interest Income | 13.81M | 19.75M | 22.08M | 5.98M | 2K | 43K |
Pretax Income | -151.2M | -163.93M | -129.45M | -147.24M | -55.11M | -26.98M |
Net Income | -68.99M | -61.19M | -35.47M | -108.03M | -55.15M | -26.75M |
Selling & General & Admin | 51.78M | 56.08M | 44.82M | 70.94M | 8.86M | 5.98M |
Research & Development | 114.12M | 127.67M | 106.71M | 82.07M | 46.26M | 21.04M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 165.9M | 183.75M | 151.52M | 153.01M | 55.11M | 27.02M |
Interest Expense | 4K | 9K | 12K | 215K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 314K |
Cost & Expenses | 165.9M | 183.75M | 151.52M | 153.01M | 55.11M | 27.02M |
Income Tax Expense | 414K | -598K | 6M | 896K | 38K | -232K |
Shares Outstanding (Basic) | 133.94M | 97.92M | 61.71M | 61.54M | 31.89M | 186.5M |
Shares Outstanding (Diluted) | 133.94M | 97.92M | 61.71M | 61.54M | 31.89M | 186.5M |
EPS (Basic) | -0.52 | -0.62 | -0.57 | -1.76 | -1.73 | -0.14 |
EPS (Diluted) | -0.52 | -0.62 | -0.57 | -1.76 | -1.73 | -0.14 |
EBITDA | -144.62M | -158.49M | -125.59M | -143.99M | -53.12M | -26.06M |
EBIT | -151.19M | -163.92M | -129.44M | -147.02M | -55.11M | -27.02M |
Depreciation & Amortization | 6.58M | 5.43M | 3.85M | 3.04M | 1.98M | 964K |
Add to Watchlist
Select watchlists to add or remove PROK